title: Anti-aging activity of the Ink4/Arf locus.
abstract: The proteins encoded by the Ink4/Arf locus, p16Ink4a, p19Arf and p15Ink4b are major tumour suppressors that oppose aberrant mitogenic signals. The expression levels of the locus are progressively increased during aging and genome-wide association studies have linked the locus to a number of aging-associated diseases and frailty in humans. However, direct measurement of the global impact of the Ink4/Arf locus on organismal aging and longevity was lacking. In this work, we have examined the fertility, cancer susceptibility, aging and longevity of mice genetically modified to carry one (Ink4/Arf-tg) or two (Ink4/Arf-tg/tg) intact additional copies of the locus. First, increased gene dosage of Ink4/Arf impairs the production of male germ cells, and in the case of Ink4/Arf-tg/tg mice results in a Sertoli cell-only-like syndrome and a complete absence of sperm. Regarding cancer, there is a lower incidence of aging-associated cancer proportional to the Ink4/Arf gene dosage. Interestingly, increased Ink4/Arf gene dosage resulted in lower scores in aging markers and in extended median longevity. The increased survival was also observed in cancer-free mice indicating that cancer protection and delayed aging are separable activities of the Ink4/Arf locus. In contrast to these results, mice carrying one or two additional copies of the p53 gene (p53-tg and p53-tg/tg) had a normal longevity despite their increased cancer protection. We conclude that the Ink4/Arf locus has a global anti-aging effect, probably by favouring quiescence and preventing unnecessary proliferation.
authors.affiliation: Tumor Suppression Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
authors.forename: Ander
authors.initials: A
authors.lastname: Matheu
authors.forename: Antonio
authors.initials: A
authors.lastname: Maraver
authors.forename: Manuel
authors.initials: M
authors.lastname: Collado
authors.forename: Isabel
authors.initials: I
authors.lastname: Garcia-Cao
authors.forename: Marta
authors.initials: M
authors.lastname: Cañamero
authors.forename: Consuelo
authors.initials: C
authors.lastname: Borras
authors.forename: Juana M
authors.initials: JM
authors.lastname: Flores
authors.forename: Peter
authors.initials: P
authors.lastname: Klatt
authors.forename: Jose
authors.initials: J
authors.lastname: Viña
authors.forename: Manuel
authors.initials: M
authors.lastname: Serrano
mesh_terms: D000375:Aging / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D049109:Cell Proliferation; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics / Q000378:metabolism*; D018628:Gene Dosage / Q000235:genetics; D016147:Genes, Tumor Suppressor / Q000502:physiology*; D007113:Immunity, Innate / Q000235:genetics*; D007248:Infertility, Male / Q000235:genetics; D008136:Longevity / Q000235:genetics*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009369:Neoplasms / Q000235:genetics* / Q000378:metabolism; D013091:Spermatogenesis / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism
chemical_list: C417743:Cdkn2a protein, mouse; D019941:Cyclin-Dependent Kinase Inhibitor p16; D016159:Tumor Suppressor Protein p53